Article

lock Open Access lock Peer-Reviewed

0

Views

HOW I DO IT

Pulmonary Thromboendarterectomy Without Circulatory Arrest

Reuben Lamiaki KyntaI; Sanjib RawatI; Mrinal MandalI; Manuj Kumar SaikiaI

DOI: 10.21470/1678-9741-2020-0534

ABSTRACT

Introduction: Here we describe our technique and results of beating heart pulmonary thromboendarterectomy (PTE) with cardiopulmonary bypass (CPB) in four patients for treatment of chronic thromboembolic pulmonary hypertension (CTEPH).
Methods: Retrospective analysis of data from patients who underwent PTE for CTEPH between January 2019 and September 2020. Patients were followed up with clinical assessment, 2D echocardiography, and computed tomography pulmonary angiogram.
Results: Four patients were operated for CTEPH using our technique. Moderate tricuspid regurgitation (TR) and severe TR were found in two patients each. Severe right ventricular (RV) dysfunction was found in all cases. Thrombi were classified as Jamieson type II in three cases and type I in one case. Postoperative median direct manometric pulmonary artery (PA) pressures decreased (from 46.5 mmHg to 23.5 mmHg), median CPB time was 126 minutes, and median temperature was 33.35 °C. Mechanical ventilation was for a median of 19.5 hours. There was one re-exploration. Median intensive care unit stay was 7.5 days. There was no mortality. Postoperative 2D echocardiography revealed decrease in median PA systolic pressures (from 85 mmHg to 33 mmHg), improvement in RV function by tricuspid annular plane systolic excursion (median 14 mm vs. 16 mm), and improved postoperative oxygen saturations (88.5% vs. 99%). In follow-up (ranging between 2-15 months), all patients reported improvement in quality of life and were in New York Heart Association class I.
Conclusion: With our described simple modifications, advances in perfusion, and blood conservation technologies, one can avoid the need for deep hypothermic circulatory arrest during PTE.

ABBREVIATIONS AND ACRONYMS

2D echo = 2D echocardiography

ABP = Arterial blood pressure

CPB = Cardiopulmonary bypass

CTEPH = Chronic thromboembolic pulmonary hypertension

CTPA = Computed tomography pulmonary angiogram

CVP = Central venous pressure

DHCA = Deep hypothermic circulatory arrest

DVP = Deep venous thrombosis

EF = Ejection fraction

ICU = Intensive care unit

IVC = Inferior vena cava

LPA = Left pulmonary artery

MAP = Mean arterial pressure

MPA = Main pulmonary artery

mPAP = Mean pulmonary artery pressure

NYHA = New York Heart Association Functional Classification

PA = Pulmonary artery

PAP = Pulmonary artery pressure

PASP = Pulmonary artery systolic pressure

PTE = Pulmonary thromboendarterectomy

RPA = Right pulmonary artery

RSPV = Right superior pulmonary vein

RV = Right ventricular

SpO2 = Oxygen saturation

SVC = Superior vena cava

TAPSE = Tricuspid annular plane systolic excursion

TR = Tricuspid regurgitation

UCSD = University of California San Diego

INTRODUCTION

Pulmonary thromboendarterectomy (PTE) is the definitive surgical treatment for chronic thromboembolic pulmonary hypertension (CTEPH)[1]. In this technique, a bloodless field is essential, and deep hypothermic circulatory arrest (DHCA) has been the preferred method to extract the pulmonary thrombus beyond the sublobar levels. However, DHCA is not devoid of its adverse effects which mainly include neurologic deficits[2,3], renal dysfunction[4,5], and bleeding[6]. In pursuit to control the troublesome back bleeding from the bronchial vessels and collaterals without the use of DHCA, several methods have been described to achieve complete thromboendarterectomy. Here, we describe our technique and modifications needed for PTE on beating heart cardiopulmonary bypass (CPB) with mild hypothermia on four patients.

METHODS

Study Design

As this was a retrospective case series, ethical clearance was waived off. Retrospective data of patients who underwent beating heart PTE from January 2019 to September 2020 at the Department of Cardiothoracic and Vascular Surgery, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (Shillong, India), were collected, and the operative records were reviewed. This study included four patients. Written and informed consent was taken. The patients were followed up with clinical assessment, investigations like transthoracic 2D echocardiography (2D echo) and computed tomography pulmonary angiogram (CTPA) were performed, and the data was collected.

Inclusion criteria were patients reporting to/referred to our department with: (a) New York Heart Association Functional Classification (NYHA) class III & IV symptoms, (b) thrombus in main, lobar, or segmental pulmonary arteries (PA) as seen in CTPA, (c) no debilitating comorbidities, and (d) 2D echo evidence of right ventricular (RV) dysfunction. All patients with acute pulmonary embolism did not fit to undergo CPB, and those for emergency pulmonary embolectomy were excluded.

Demographic variables, pulmonary artery pressure (PAP) (systolic, diastolic, and mean), RV dysfunction as measured by tricuspid annular plane systolic excursion (TAPSE) on 2D echo, central venous pressure (CVP), oxygen saturation (SpO2), CPB time, location of thrombus as described by Jamieson’s classification as well as University of California San Diego (UCSD) surgical classification, postoperative course, and any postoperative complications were studied.

Pulmonary artery systolic pressure (PASP) was measured by pre- and postoperative echocardiogram. PAP was measured intraoperatively before and after PTE by direct needle manometry of main pulmonary artery (MPA). CVP and SpO2 were measured before and after PTE.

Anesthetic Management

Anesthesia was induced by intravenous administration of morphine, fentanyl, and vecuronium and maintained with intravenously administered propofol and inhalation of isoflurane. Monitoring was done by a radial artery line, central venous line, electrocardiography, nasopharyngeal and rectal thermometer, and transesophageal echocardiography. The heart rate was regulated to 60-70 beats per minute by boluses of beta blocker metoprolol.

CPB Pump and Autologous Blood Conservation Setup

Standard CPB circuit with St. Thomas II cardioplegia on standby and a cell saver (C.A.T.S®, Fresenius Kabi) is established. An aortic cannula and two straight venous cannulae for bicaval cannulation of appropriate size are used. Four pump suction lines are readied for a free cardiotomy sucker, vent sucker of the right superior pulmonary vein (RSPV), right ventricle, and either of the PAs (Figures 1 and 2). A hemoconcentrator for ultrafiltration is connected to the bypass circuit to achieve negative fluid balance. Core temperature is decreased to 32-34 °C (mild hypothermia), and flows are maintained at 2 to 2.4 l/min/m2. A high-pressure external sucker attached to the cell saver is used to connect an olive tip sucker, which is used as a dissector. The α-stat strategy of pH management is employed.

Fig. 1 - Cannulae and vent setup. Main pulmonary artery (MPA) arteriotomy extending to left pulmonary artery (LPA) with cardiotomy sucker in LPA shown. IVC=inferior vena cava; RPA=right pulmonary artery; RV=right ventricular; RSPV=right superior pulmonary vein; SVC=superior vena cava

Fig. 2 - Cartoon of cannulae and vent setup. IVC=inferior vena cava; LPA=left pulmonary artery; MPA=main pulmonary artery; RPA=right pulmonary artery; RV=right ventricular; RSPV=right superior pulmonary vein; SVC=superior vena cava

Instruments Required

Two DeBakey vascular forceps (23 cm length), two ventricular septal defect retractors (23 cm length), one olive tip sucker connected to cell saver, a mastoid retractor with rubber inserts on blade tips, and a vascular clamp (straight or angled) are required (Figure 3).

Fig. 3 - Instruments required: A) Mastoid retractor with rubber inserts on blade tips; B) Olive tip sucker; C) Ventricular septal defect retractors (23 cm length); D) DeBakey vascular forceps (23 cm length).

Surgical Technique

The operation is performed via a median sternotomy. After an inverted T pericardiotomy and attachment to the wound edges, direct pressure manometry by puncturing MPA is done. The superior vena cava (SVC) is looped and mobilized by cautery dissection. Mobilization of the branch PA is done intrapericardially, and none of the pleurae are opened. The aorta is looped with a vessel loop for better visualization (Figures 1 and 2).

CPB is established by cannulating the ascending aorta and both caval veins after achieving an activated clotting time of > 480 seconds with heparinization (300 U/kg).

A straight cannula in the SVC is guided high, near to the convergence of the innominate vein via the right atrial appendage, and snared. This method of cannulation further helps in proximal mobilization of the SVC. The inferior vena cava is cannulated and snared. An antegrade aortic root cardioplegia needle is inserted should the need for DHCA arise.

A vent catheter is introduced into the RSPV. The left pulmonary artery (LPA) is then dissected beyond the origin of the upper lobe artery with careful preservation of the left phrenic nerve. A small arteriotomy is made in the right pulmonary artery (RPA) just right to the aorta, and a vent catheter is introduced into it and snared. Ventilation is then stopped.

With the surgeon standing on the right side of the patient, an incision is then made in the MPA and is extended into the LPA beyond the origin of the upper lobe artery. Stay sutures are taken and the arteriotomy is exposed. A sump sucker is introduced into the right ventricle via the pulmonary valve and snared through the MPA wall. If bleeding from the RPA obscure the field of view, a vascular clamp may be applied upstream to the RPA vent.

Any fresh or loose clots are removed for visualization of the chronic thrombus. Thromboendoarterectomy then commences with creation of the correct plane in the media. The correct plane appears as a smooth pearly white structure which is amenable to peeling with controlled traction, countertraction, and a sweeping motion of the olive tipped sucker (Figure 4). The free cardiotomy sucker is employed to clear blood from the field. The surgeon should pay his/her undivided attention to the plane of dissection and should not shift his/her field of view for exchanging instruments.

Fig. 4 - Delineation of the true plane of dissection in pulmonary thromboendarterectomy. PA=pulmonary artery.

Meanwhile, the blood collected from the cell saver is then transferred to the cardiotomy reservoir. In the endarterectomy of the sublobar branches, traction and dissection of the thrombus evert the media, and this may risk perforation of the PA. One should gently extract the thrombus which should come out spontaneously with its tapered tail (Figure 5).

Fig. 5 - Computed tomography pulmonary angiogram and thromboendarterectomy specimen of patient 4.

After the endarterectomy, gentle positive pressure ventilation is initiated by the anesthetist to check for breach of PA wall which appears as air bubbles in the operating field. Brisk bright red back bleeding is an indirect sign of clearance from the endarterectomized segment.

For final confirmation, an endoscope (5 mm diameter, 0 degree) is inserted into the LPA and clearance is confirmed in each segment with the olive tipped sucker clearing the bronchial back bleed. The thrombus extracted is examined in toto to confirm complete PTE in all segments.

The RPA clamp is removed, and the incision is then extended from the vent insertion site to the right lower lobe branch just after the takeoff of the middle lobe artery. Visualization of the RPA tree is partially obscured due to the SVC running above it. Here, the modified mastoid retractor is applied between the SVC and aorta for better visualization of the pulmonary arterial tree. Alternatively, the SVC can also be retracted to the left for better viewing of the descending lobar branches. The dissection is carried out and the steps are analogous to the left as described.

Upon completion, the pulmonary arteriotomies are closed in two layers with 5-0 polypropylene sutures. The patient is then weaned off CPB; direct PA pressure manometry is done, and chest is closed after heparinization reversal and hemostasis.

RESULTS

A total of four patients were operated for CTEPH from January 2019 to September 2020. Patient preoperative data is presented in Table 1. Preoperative transthoracic echocardiographic imaging revealed severe pulmonary hypertension with a median PASP of 85 mmHg, moderate tricuspid regurgitation (TR) in two patients, and severe TR in two patients. Severe RV dysfunction was found in all cases.

Table 1 - Perioperative details of patients undergoing beating heart pulmonary thromboendarterectomy.
PREOPERATIVE FINDINGS
Patient 1 Patient 2 Patient 3 Patient 4 Median
Age (years) 23 24 46 47 35
Sex Male Male Female Male
Preoperative ICU admission - - - -
DVT - - - -
NYHA class III IV III IV
2D echo
EF (%) 60 60 57 60 60%
PASP (mmHg) 72 68 98 120 85 mmHg
TR Severe Moderate Severe Moderate
TAPSE (mm) 15 18 13 13 14 mm
Preoperative CTPA
RPA, mm 16 *29 *21 35
LPA, mm *19 *26 *23 *33
MPA, mm *24 40 34 *39
INTRAOPERATIVE FINDINGS
Jamieson class II I II II (LPA only)
UCSD surgical class I I I IC left
CPB time (minutes) 108 117 135 161 126
Minimum temp (°C) 28 33.9 33.7 33 33.35
SpO2 (%)
Preoperative 89 79 88 93 88.5
Postoperative 99 99 100 99 99
CVP
Preoperative 25 22 19 26 23.5
Postoperative 13 12 12 11 12
ABP (systolic/diastolic/mean in mmHg)
Preoperative 98/60/73 78/40/52 74/49/57 145/110/122 MAP 65
Postoperative 118/82/94 78/51/60 116/69/85 131/51/78 MAP 81.5
PAP (systolic/diastolic/mean in mmHg)
Preoperative 65/34/44 51/48/49 24/15/18 104/49/67 mPAP 46.5
Postoperative 35/20/25 27/20/22 28/17/21 40/26/31 mPAP 23.5
POSTOPERATIVE FINDINGS
Re-exploration No No No Yes
Ventilation (hours) 24 15 12 96 19.5
ICU stay (days) 4 3 11 14 7.5
Hospital stay (days) 23 29 22 40 26
NYHA class I I I I
2D echo
EF (%) 58 60 60 65 60%
PASP (mmHg) 30 25 40 36 33 mmHg
TR Trace Trace Moderate Mild
TAPSE (mm) 20 16 15 16 16 mm
Postoperative CTPA
RPA, mm 18 19 17 24
LPA, mm 22 10 20 18
MPA, mm 28 35 33 34
Follow-up (months) 15 14 4 2 9

* Thrombus 2D echo=2D echocardiography; ABP=arterial blood pressure; CPB=cardiopulmonary bypass; CTPA=computed tomography pulmonary angiogram; CVP=central venous pressure; DVT=deep venous thrombosis; EF=ejection fraction; ICU=intensive care unit; LPA=left pulmonary artery; MAP=mean arterial pressure (in mmHg); MPA=main pulmonary artery; mPAP=mean pulmonary artery pressure (in mmHg); NYHA=New York Heart Association Functional Classification; PAP=pulmonary artery pressure (by needle manometry); PASP=pulmonary artery systolic pressure; RPA=right pulmonary artery; SpO2=oxygen saturation; TAPSE=tricuspid annular plane systolic excursion; TR=tricuspid regurgitation; UCSD=University of California San Diego

Table 1 - Perioperative details of patients undergoing beating heart pulmonary thromboendarterectomy.

Before PTE, intraoperative needle manometry revealed median preoperative PAP of 46.5 mmHg (Table 1). The thrombi removed were classified as Jamieson type II in three cases and type I in one case[1]. As per the UCSD surgical classification[7], the thrombi were classified as class I in all cases with one case having complete occlusion of the LPA (IC left) (Table 1). Post PTE, needle manometry showed decreased median PAP of 23.5 mmHg (Table 1). The median CPB time was 126 minutes, and the median temperature was 33.35 °C (Table 1).

Patients postoperatively received mechanical ventilation for a median of 9.5 hours (Table 1). There was one re-exploration for bleeding, and the same patient had prolonged ventilation for 96 hours. The median intensive care unit stay was 7.5 days. There was no mortality. The median hospital stay was 26 days (Table 1).

Postoperative echocardiographic examination revealed decrease in median PASP (from 85 mmHg to 33 mmHg). Improvement in RV function was derived by TAPSE on 2D echo (median: 14 mm vs. 16 mm) (Table 1). Median postoperative SpO2 also showed improvement (88.5% vs. 99%). Postoperatively, over a follow-up ranging between 2-15 months, all patients reported improvement in their quality of life and were in NYHA class I (Table 1). There were no neurologic complications.

DISCUSSION

PTE is the definitive treatment of CTEPH[1]. From its evolution of embolectomy to the current standard thromboendarterectomy, it cannot be over emphasized that complete clearance of the organized thrombus in the correct plane is vital for good outcomes[8]. Utley et al.[9] emphasized that circulatory arrest was absolutely essential for distal segmental vessel thromboendarterectomy because of the increased bronchial circulation.

The use of DHCA and the adverse effects have been extensively described in literature for the conduct of PTE[2-6]. However, different strategies to avoid the side effects of DHCA, to obtain a relatively bloodless field, and to decrease operating time have been described.

In our procedure, we use four pump suckers and one external sucker connected to cell saver which helps us in obtaining a bloodless field. DHCA and its potential complications are thus avoided. Balloon catheter occlusion of the descending aorta to obtain a bloodless field as described by Hagl with the abovementioned setup was not needed[10].

In our modifications for performing PTE on beating heart with CPB, we avoid division of the great vessels without compromising clearance, thereby minimizing vascular trauma[9,10]. As the procedure is conducted on beating heart with CPB support, we negate the need of complex cannulation of the aortic arch vessels for selective antegrade cerebral perfusion for PTE[11-13]. Our method of PTE differs from the method described by Mikus et al.[14] in the fact that we use extensive venting of the left atrium via the RSPV, the right ventricle, the contralateral PA, and do not arrest the heart. We, however, follow a strategy of blood conservation similar to the described by the author by using a negative suction dissector connected to a cell saver. We also differ from the technique described by Bisoi et al.[15] because we vent the RSPV and do not transect the SVC.

In our series, the hospital stay was prolonged because we are located in a remote area with poor patient compliance on follow-up. Our low-cost modifications for the conduct of PTE in this resource poor region are unique because of the use of mild hypothermia, the avoidance of cardioplegic arrest, avoidance of transection of the great vessels, and the ability to obtain a relatively bloodless field using external negative suction. The thorough checking of clearance the endarterectomized field by an endoscope also ensures that we can address remaining thrombus burden in the same setting.

Limitations

This study has its limitations. First, it was a retrospective analysis covering a 20-month period. Second, small sample size is a limiting factor to gain significant results. However, we believe this study may provide some useful information for the surgical management of CTEPH patients

CONCLUSION

The definitive treatment of chronic pulmonary hypertension is the complete evacuation of the thrombus load in the pulmonary vascular tree. Thromboendarterectomy under DHCA has been the most commonly technique employed to omit bronchial back bleed. Advances in perfusion, blood conservation, and our described modifications can make it possible to avoid circulatory arrest. However, the superiority of our technique cannot be established in view of the small number of cases.

REFERENCES


1. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457-62; discussion 1462-4. doi:10.1016/s0003-4975(03)00828-2.

2. Kamenskaya OV, Cherniavsky AM, Klinkova AS, Cherniavsky MA, Meshkov IO, Lomivorotov VV, et al. Efficiency of various cerebral protection techniques used during the surgical treatment of chronic pulmonary thromboembolism. J Extra Corpor Technol. 2015;47(2):95-102. [MedLine]

3. Tian Tian DH, Wan B, Bannon PG, Misfeld M, LeMaire SA, Kazui T, et al. A meta-analysis of deep hypothermic circulatory arrest versus moderate hypothermic circulatory arrest with selective antegrade cerebral perfusion. Ann Cardiothorac Surg. 2013;2(2):148-58. doi:10.3978/j.issn.2225-319X.2013.03.13. [MedLine]

4. Yu L, Gu T, Zhang G, Cheng S, Fang Q, Mao N. The deep hypothermic circulatory arrest causes more kidney malfunctions based on a novel rabbit model. Ann Saudi Med. 2014;34(6):532-40. doi:10.5144/0256-4947.2014.532. [MedLine]

5. Zhang C, Wang G, Zhou H, Lei G, Yang L, Fang Z, et al. Preoperative platelet count, preoperative hemoglobin concentration and deep hypothermic circulatory arrest duration are risk factors for acute kidney injury after pulmonary endarterectomy: a retrospective cohort study. J Cardiothorac Surg. 2019;14(1):220.

6. Mazzeffi M, Marotta M, Lin HM, Fischer G. Duration of deep hypothermia during aortic surgery and the risk of perioperative blood transfusion. Ann Card Anaesth. 2012;15(4):266-73.

7. Jenkins D, Madani M, Fadel E, D'Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160111. doi:10.1183/16000617.0111-2016.

8. Sakurai Y, Takami Y, Amano K, Higuchi Y, Akita K, Noda M, et al. Predictors of outcomes after surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg. 2019;108(4):1154-61. doi:10.1016/j.athoracsur.2019.03.100.

9. Jamieson SW. Historical perspective: surgery for chronic thromboembolic disease. Semin Thorac Cardiovasc Surg. 2006;18(3):218-22. doi:10.1053/j.semtcvs.2006.09.007.

10. Hagl C, Khaladj N, Peters T, Hoeper MM, Logemann F, Haverich A, et al. Technical advances of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Eur J Cardiothorac Surg. 2003;23(5):776-81; discussion 781. doi:10.1016/ s1010-7940(03)00029-0.

11. Masuda M, Mogi K, Nakaya M, Pearce Y, Imamaki M, Shimura H, et al. Surgical treatment for chronic pulmonary thromboembolism under cardiopulmonary bypass with selective cerebral perfusion. Surg Today. 2001;31(2):108-12.

12. Thomson B, Tsui SS, Dunning J, Goodwin A, Vuylsteke A, Latimer R, et al. Pulmonary endarterectomy is possible and effective without the use of complete circulatory arrest--the UK experience in over 150 patients. Eur J Cardiothorac Surg. 2008;33(2):157-63. doi:10.1016/j. ejcts.2007.11.009.

13. Lafci G, Tasoglu I, Ulas MM, Yalcinkaya A, Cagli K. Pulmonary endarterectomy: with use of moderate hypothermia and antegrade cerebral perfusion without circulatory arrest. Tex Heart Inst J. 2012;39(1):65-7.

14. Mikus PM, Dell'Amore A, Pastore S, Galiè N. Pulmonary endarterectomy: is there an alternative to profound hypothermia with cardiocirculatory arrest? Eur J Cardiothorac Surg. 2006;30(3):563-5. doi:10.1016/j.ejcts.2006.06.016.

15. Bisoi AK, Ramakrishnan P, Chauhan S, Sahu MK, Chandrasekharan NC. An experience on normothermic beating heart pulmonary thromboendarterectomy. W J Cardiovasc Surg. 2019;9(1):1-3. doi:10.4236/wjcs.2019.91001.

Authors' roles & responsibilities

RLK Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published

SR Drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published

MM Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published

MKS Final approval of the version to be published

Article receive on Wednesday, October 7, 2020

Article accepted on Thursday, February 11, 2021

CCBY All scientific articles published at rbccv.org are licensed under a Creative Commons license

Indexes

All rights reserved 2017 / © 2022 Brazilian Society of Cardiovascular Surgery DEVELOPMENT BY